Genistein-induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity

Molecular Pharmacology

Volumn 51, Issue 2, 1997, Pages 193-200

  Kyle, Edward ^a   Neckers, Len ^a   Takimoto, Chris ^a   Curt, Gregory ^a   Bergan, Raymond ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENISTEIN; ISOFLAVONOID;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL ADHESION; CONTROLLED STUDY; METASTASIS; PRIORITY JOURNAL; PROSTATE CARCINOMA; SOYBEAN;

EID: 0031017360     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.51.2.193     Document Type: Article

References (35)

1. Parker, S. L., T. Tong, S. Bolden, and P. A. Wingo. Cancer statistics, 1996. CA Cancer J. Clin. 46:5-27 (1996).
2. Dawson, N. A., K. Kobayashi, and N. J. Vogelzang. Recent therapeutic advances in "hormone-refractory" metastatic prostate cancer: flutamide withdrawal, estramustine plus vinblastine, estramustine plus etoposide, and suramin, in Prostate Cancer (N. A. Dawson and N. J. Vogelzang, eds.). Wiley, New York, 235-260 (1994).
3. Cher, M. L., K. Chew, W. Rosenau, and P. R. Carroll. Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression. Prostate 26:87-93 (1995).
4. Rowley, D. R., T. D. Dang, L. McBride, M. J. Gerdes, B. Lu, and M. Larsen. Beta-2 microglobulin is mitogenic to PC-3 prostatic carcinoma cells and antagonistic to transforming growth factor beta 1 action. Cancer Res. 55:781-786 (1995).
5. Carruba, G., R. E. Leake, F. Rinaldi, D. Chalmers, L. Comito, C. Sorci, M. M. Pavone, and L. A. Castagnetta. Steroid-growth factor interaction in human prostate cancer. 1. Short-term effects of transforming growth factors on growth of human prostate cancer cells. Steroids 59:412-420 (1994).
6. Yang, C., C. Cirielli, M. C. Capogrossi, and A. Passaniti. Adenovirus-mediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of prostatic tumor cells. Cancer Res. 55:4210-4213 (1995).
7. Raffo, A. J., H. Perlman, M. W. Chen, M. L. Day, J. S. Streitman, and R. Buttyan. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res. 55:4438-4445 (1995).
8. Bergan, R., E. Kyle, P. Nguyen, J. Trepel, and L. Neckers. Genistein-stimulated adherence of prostate cancer cells is associated with the binding of focal adhesion kinase to beta-1-integrin. Clin. Exp. Metastasis 14: 389-398 (1996).
9. Bergan, R. C., M. Blagosklonny, N. Dawson, d. Headlee, W. D. Figg, L. Neckers, and C. E. Myers. Significant activity by high dose tamoxifen in hormone refractory prostate cancer. Proc. Am. Soc. Clin. Oncol. Annu. Meet. 14:32 (1995).
10. Adlercreutz, H. Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand. J. Clin. Lab. Invest. 50(Suppl. 201):3-23 (1990).
11. Severson, R. K., A. M. Nomura, J. S. Grove, and G. N. Stemmermann. A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res. 49:1857-1860 (1989).
12. Adlercreutz, H., H. Markkanen, and S. Watanabe. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 342:1209-1210 (1993).
13. Mills, P. K., W. L. Beeson, R. L. Phillips, and G. E. Fraser. Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer 64(3):598-604 (1989).
14. Burke, T. R. Protein-tyrosine kinase inhibitors. Drugs Future 17:119-131 (1992).
15. Hollenberg, M. D. Tyrosine kinase-mediated signal transduction pathways and actions of polypeptide growth factors and G-protein-coupled agonists in smooth muscle. Mol. Cell Biochem. 149:77-85 (1995).
16. Simon, H. U., S. Yousefi, and K. Blaser. Tyrosine phosphorylation regulates activation and inhibition of apoptosis in human eosinophils and neutrophils. Int. Arch. Allergy Appl. Immunol. 107:338-339 (1995).
17. Peterson, G., and S. Barnes. Genistein and biochanin A inhibit the growth of human cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation. Prostate 22:335-345 (1993).
18. Kozlowski, J. M., J. F. Isaiah, D. Campbell, Z. L. Xu, M. E. Kaighn, and I. R. Hart. Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res. 44:3522-3529 (1984).
19. Peterson, G., and S. Barnes. Genistein inhibition of the growth of human breast cancer cells independence from estrogen receptors and the multi-drug resistance gene. Biochem. Biophys. Res. Commun. 179:661-667 (1991).
20. Bergan, R., Y. Connell, B. Fahmy, and L. Neckers. Electroporation enhances c-myc antisense oligodeoxynucleotide efficacy. Nucleic Acids Res. 21:3567-3573 (1993).
21. Bergan, R. C., E. Kyle, Y. Connell, and L. Neckers. Inhibition of protein-tyrosine kinase activity in intact cells by the aptameric action of oligodeoxynucleotides. Antisense Res. Dev. 5:33-38 (1995).
22. Sartor, O., J. H. Sameshima, and K. C. Robbins. Differential association of cellular proteins with family protein-tyrosine kinases. J. Biol Chem. 266: 6462-6466 (1991).
23. Farmakalidis, E., J. N. Hathcock, and P. A. Murphy. Oestrogenic potency of genistin and daidzin in mice. Food Chem. Toxicol. 23:741-745 (1985).
24. Carruba, G., U. Pfeffer, E. Fecarotta, D. A. Coviello, E. D'Amato, M. Lo Castro, G. Vidali, and L. Castagnetta. Estradiol inhibits growth of hormone-nonresponsive PC3 prostate cancer cells. Cancer Res. 54:1190-1193 (1994).
25. Castagnetta, L., M. Lo Casto, T. Mercadante, L. Polito, S. Cowan, and R. E. Leake. Intra-tumoural variation of oestrogen receptor status in endometrial cancer. Br. J Cancer. 47:261-267 (1983).
26. Castagnetta, L., G. Carruba, E. Fecarotta, M. Lo Casto, R. Cusimano, and M. Pavone-Macaluso. Soluble and nuclear type I and II androgen binding sites in benign hyperplasia and cancer of the human prostate. Urol. Res. 20:127-132 (1992).
27. Turcotte, G., A. Chapdelaine, K. D. Roberts, and S. Chevalier. Androgen binding as evidenced by a whole cell assay system using cultured canine prostatic epithelial cells. J. Steroid Biochem. 29:69-76 (1988).
28. Rosales, C., V. O'Brien, L. Kornberg, and R. Juliano. Signal transduction by cell adhesion receptors. Biochim. Biophys. Acta. 1242:77-98 (1995).
29. Matsukawa, Y., N. Marui, T. Sakai, Y. Satomi, M. Yoshida, K. Matsumoto, H. Nishino, and A. Aoike. Genistein arrests cell cycle progression at G2-M. Cancer Res. 53:1328-1331 (1993).
30. Tremblay, L., A. Aprikian, and S. Chevalier. Expression of focal adhesion kinase in prostate cancer. Proc. Am. Assoc. Cancer Res. Annu. Meet. 36:64 (1995).
31. Xu, L., L. V. Owens, G. C. Sturge, X. Yang, E. T. Liu, R. J. Craven, and W. G. Cance. Attenuation of the expression of the focal adhesio kinase induces apoptosis in tumor cells. Cell Growth Differ. 7:413-418 (1996).
32. Giri, A. K., and L. J. Lu. Genetic damage and the inhibition of 7,12-dimethylbenz[a]anthracene-induced genetic damage by the phytoestrogens, genistein and daidzein, in female ICR mice. Cancer Lett. 95:125-33 (1995).
33. Wei, H., R. Bowen, Q. Cai, S. Barnes, and Y. Wang. Antioxidant and antipromotional effects of the soybean genistein. Proc. Soc. Exp. Biol. Med. 208:124-130 (1995).
34. Supko, J. G., and L. Malspeis. Plasma pharmacokinetics of genistein in the mouse and beagle dog. Proc. Am. Assoc. Cancer Res. Annu. Meet. 36:2279 (1995).
35. East, J. The effect of genistein on the fertility of mice. J. Endocrinol. 13:94-100 (1955).